Trial intelligence / Profile preview

METODO: Methoxyflurane vs placebo for pain in oral and dental emergencies

2023-508216-29-00Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Brest
Start
Mar 2024
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in odontalgia comparing Methoxyflurane (Penthrox) with Placebo (2 arms). Primary endpoint: Change in pain intensity from baseline to 15 minutes post-treatment. Started Mar 2024; status: completed.

02

Drugs

methoxyflurane
03

Conditions

odontalgia

Beyond the preview

Go deeper on 2023-508216-29-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2023-508216-29-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call